Your prediction
Braskem Pfd ADR Stock
A loss of -1.610% shows a downward development for Braskem Pfd ADR.
Pros and Cons of Braskem Pfd ADR in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Braskem Pfd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Braskem Pfd ADR | -1.610% | -1.587% | 19.231% | -45.374% | -31.111% | -72.747% | -64.058% |
| Braskem Pfd A | -0.850% | -1.681% | 11.429% | -47.297% | -38.743% | -74.000% | -68.033% |
| Ingevity Corp | 3.980% | 6.139% | 11.184% | 9.500% | 24.142% | - | - |
| PTT Global Chemical -fgn- | - | -0.962% | -3.738% | -22.556% | -20.769% | -58.468% | -68.012% |
Comments
Braskem S.A. (NYSE: BAK) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating.
Show more
Ratings data for BAK provided by MarketBeat